Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

Journal of Experimental Medicine

Volumn 196, Issue 11, 2002, Pages 1497-1506

  Nagy, Janice A ^a   Vasile, Eliza ^a   Feng, Dian ^a   Sundberg, Christian ^a,b   Brown, Lawrence F ^a   Detmar, Michael J ^a   Lawitts, Joel A ^a   Benjamin, Laura ^a   Tan, Xiaolian ^a   Manseau, Eleanor J ^a   Dvorak, Ann M ^a   Dvorak, Harold F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

PlGF; VEGF A; VEGF C; VEGF D; VPF VEGF

Indexed keywords

ADENOVIRUS VECTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG EFFECT; GIANT CELL; LYMPH FLOW; LYMPH VESSEL; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FAMILY; SCID MOUSE;

ADENOVIRIDAE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; LYMPHOKINES; LYMPHOMA; MICE; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037011070     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021244     Document Type: Article

References (40)

1. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science. 277:48-50.
2. Folkman, J. 1997. Angiogenesis and angiogenesis inhibition: An overview. EXS. 79:1-8.
3. Beck, L., Jr., and P.A. D'Amore. 1997. Vascular development: Cellular and molecular regulation. FASEB J. 11:365-373.
4. Gale, N.W., and G.D. Yancopoulos, 1999. Growth factors acting via endothehal cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1055-1066.
5. Brown, L.F., M. Detmar, K. Claffey, J.A. Nagy, D. Feng, A.M. Dvorak, and H.F. Dvorak. 1997. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS. 79:233-269.
6. Carmeliet, P., and D. Collen. 1999. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol. 237:133-158.
7. Dvorak, H.F., J.A. Nagy, D. Feng, L.F. Brown, and A.M. Dvorak. 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237:97-132.
8. Ferrara, N. 1999. Vascular endothelial growth factor: Molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237:1-30.
9. Luttun, A., M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, F. Liao, J.A. Nagy, A. Hooper, J. Priller, B. De Klerck, et al. 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Fit1. Nat. Med. 8:831-840.
10. Cao, Y., P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar, J.H. Qi, L. Claesson-Welsh, and K. Alitalo. 1998. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA. 95:14389-14394.
11. Achen, M.G., M. Jeltsch, E. Kukk, T. Makinen, A. Vitali, A.F. Wilks, K. Alitalo, and S.A. Stacker. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. 95:548-553.
12. Karkkainen, M.J., R.E. Ferrell, E.C. Lawrence, M.A. Kimak, K.L. Levinson, M.A. McTigue, K. Alitalo, and D.N. Finegold. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25:153-159.
13. Skobe, M., T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, P. Velasco, L. Riccardi, K. Alitalo, K. Claffey, and M. Detmar. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-198.
14. Enholm, B., T. Karpanen, M. Jeltsch, H. Kubo, F. Stenback, R. Prevo, D.G. Jackson, S. Yla-Herttuala, and K. Alitalo. 2001. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88:623-629.
15. Jussila, L., and K. Alitalo. 2002. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82:673-700.
16. Oliver, G., and M. Detmar. 2002. The rediscovery of the lymphatic system: Old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16:773-783.
17. Oh, S.J., M.M. Jeltsch, R. Birkenhager, J.E. McCarthy, H.A. Weich, B. Christ, K. Alitalo, and J. Wilting. 1997. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188:96-109.
18. Byzova, T.V., C.K. Goldman, J. Jankau, J. Chen, G. Cabrera, M.G. Achen, S.A. Stacker, K.A. Carnevale, M. Siemionow, S.R. Deitcher, and P.E. DiCorleto. 2002. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood. 99:4434-4442.
19. Saaristo, A., T. Veikkola, B. Enholm, M. Hytonen, J. Arola, K. Pajusola, P. Turunen, M. Jeltsch, M.J. Karkkainen, D. Ketjaschki, et al. 2002. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16:1041-1049.
20. Pettersson, A., J.A. Nagy, L.F. Brown, C. Sundberg, E. Morgan, S. Jungles, R. Carter, J.E. Krieger, E.J. Manseau, V.S. Harvey, et al. 2000. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80:99-115.
21. Sundberg, C., J.A. Nagy, L.F. Brown, D. Feng, I.A. Eckelhoefer, E.J. Manseau, A.M. Dvorak, and H.F. Dvorak. 2001. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am. J. Pathol. 158:1145-1160.
22. Nagy, J.A., E.S. Morgan, K.T. Herzberg, E.J. Manseau, A.M. Dvorak, and H.F. Dvorak. 1995. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res. 55:376-385.
23. Feng, D., J.A. Nagy, R.A. Brekken, A. Pettersson, E.J. Manseau, K. Pyne, R. Mulligan, P.E. Thorpe, H.F. Dvorak, and A.M. Dvorak. 2000. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J. Histochem. Cytochem. 48:545-556.
24. Prevo, R., S. Banerji, D.J. Ferguson, S. Clasper, and D.G. Jackson. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:19420-19430.
25. Brown, L.F., B.J. Dezube, K. Tognazzi, H.F. Dvorak, and G.D. Yancopoulos. 2000. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 156:2179-2183.
26. Hudack, S., and P.D. McMaster. 1932. I. The permeability of the wall of the lymphatic capillary. J. Exp. Med. 56:223-238.
27. Pullinger, B.D., and H.W. Florey. 1935. Some observations on the structure and functions of lymphatics: Their behavior in local edema. J. Exp. Pathol. 16:49-61.
28. Leak, L.V. 1970. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc. Res. 2:361-391.
29. Partanen, T.A., T. Makinen, J. Arola, T. Suda, H.A. Weich, and K. Alitalo. 1999. Endothelial growth factor receptors in human fetal heart. Circulation. 100:583-586.
30. Feng, D., J. Nagy, H. Dvorak, and A. Dvorak. 2002. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc. Res. Tech. 57:289-326.
31. Skobe, M., and M. Detmar. 2000. Structure, function, and molecular control of the skin lymphatic system. J. Investig. Dermatol. Symp. Proc. 5:14-19.
32. Stacker, S.A., M.E. Baldwin, and M.G. Achen. 2002. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 16:922-934.
33. Zeng, H., H.F. Dvorak, and D. Mukhopadhyay. 2001. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J. Biol. Chem. 276:26969-26979.
34. McKee, P. 1996. Pathology of the Skin with Clinical Correlations. Mosby International, London. 16.74.
35. Lymboussaki, A., T.A. Partanen, B. Olofsson, J. Thomas-Crusells, C.D. Fletcher, R.M. de Waal, A. Kaipainen, and K. Alitalo. 1998. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am. J. Pathol. 153:395-403.
36. Huang, H.Y., C.C. Ho, P.H. Huang, and S.M. Hsu. 2001. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Lab. Invest. 81:1729-1734.
37. Dvorak, A.M., R.A. Monahan, J.E. Osage, and G.R. Dickersin. 1980. Crohn's disease: Transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum. Pathol. 11:606-619.
38. Goldman, H. 1998. Ulcerative colitis and Crohn's disease. In Pathology of the Gastrointestinal Tract. S.-C. Ming and H. Goldman, editors. Williams and Wilkins, Baltimore, MD. 673-717.
39. Kanazawa, S., T. Tsunoda, E. Onuma, T. Majima, M. Kagiyama, and K. Kikuchi. 2001. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation. Am. J. Gastroenterol. 96:822-828.
40. + monocytes. Dig. Dis. Sci. 44:1196-1201.